Yorki Tayrouz

420 total citations
12 papers, 343 citations indexed

About

Yorki Tayrouz is a scholar working on Pediatrics, Perinatology and Child Health, Molecular Biology and Pharmacology. According to data from OpenAlex, Yorki Tayrouz has authored 12 papers receiving a total of 343 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pediatrics, Perinatology and Child Health, 3 papers in Molecular Biology and 3 papers in Pharmacology. Recurrent topics in Yorki Tayrouz's work include Drug Transport and Resistance Mechanisms (3 papers), Pharmacological Effects and Toxicity Studies (3 papers) and Antibiotics Pharmacokinetics and Efficacy (3 papers). Yorki Tayrouz is often cited by papers focused on Drug Transport and Resistance Mechanisms (3 papers), Pharmacological Effects and Toxicity Studies (3 papers) and Antibiotics Pharmacokinetics and Efficacy (3 papers). Yorki Tayrouz collaborates with scholars based in Germany, United States and Netherlands. Yorki Tayrouz's co-authors include Walter E. Haefeli, Jürgen Burhenne, Gerd Mikus, Reinhard Ding, Klaus‐Dieter Riedel, Torsten Hoppe‐Tichy, Johanna Weiß, Jens Rengelshausen, I. Walter‐Sack and Rolf Aderjan and has published in prestigious journals such as Clinical Pharmacology & Therapeutics, Clinical Pharmacokinetics and British Journal of Clinical Pharmacology.

In The Last Decade

Yorki Tayrouz

12 papers receiving 335 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yorki Tayrouz Germany 9 95 90 68 51 47 12 343
Kosuke Doki Japan 12 102 1.1× 84 0.9× 93 1.4× 88 1.7× 51 1.1× 39 493
PE Rolan United Kingdom 6 56 0.6× 50 0.6× 63 0.9× 75 1.5× 26 0.6× 7 382
G. Ahr Germany 12 96 1.0× 108 1.2× 123 1.8× 75 1.5× 49 1.0× 22 571
Dale K. Yu United States 12 148 1.6× 106 1.2× 95 1.4× 59 1.2× 32 0.7× 24 436
Seong Bok Jang South Korea 13 100 1.1× 81 0.9× 82 1.2× 47 0.9× 19 0.4× 34 387
Shiew-Mei Huang United States 6 123 1.3× 99 1.1× 149 2.2× 75 1.5× 15 0.3× 7 418
Reinhard Ding Germany 11 139 1.5× 109 1.2× 88 1.3× 57 1.1× 79 1.7× 13 403
Kerstin Röhss Sweden 18 70 0.7× 61 0.7× 115 1.7× 79 1.5× 33 0.7× 45 1.1k
Ramana Uppoor United States 12 51 0.5× 185 2.1× 89 1.3× 63 1.2× 107 2.3× 26 531
Festus A. Ogunbona Nigeria 13 53 0.6× 68 0.8× 107 1.6× 51 1.0× 28 0.6× 24 370

Countries citing papers authored by Yorki Tayrouz

Since Specialization
Citations

This map shows the geographic impact of Yorki Tayrouz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yorki Tayrouz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yorki Tayrouz more than expected).

Fields of papers citing papers by Yorki Tayrouz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yorki Tayrouz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yorki Tayrouz. The network helps show where Yorki Tayrouz may publish in the future.

Co-authorship network of co-authors of Yorki Tayrouz

This figure shows the co-authorship network connecting the top 25 collaborators of Yorki Tayrouz. A scholar is included among the top collaborators of Yorki Tayrouz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yorki Tayrouz. Yorki Tayrouz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Gottwald‐Hostalek, Ulrike & Yorki Tayrouz. (2024). A review of the safety of triiodothyronine in combination with levothyroxine for the management of hypothyroidism. Current Medical Research and Opinion. 40(12). 2109–2116. 2 indexed citations
2.
Gottwald‐Hostalek, Ulrike & Yorki Tayrouz. (2021). Real world clinical experience with a new formulation of levothyroxine engineered to meet new and stricter regulatory requirements. Current Medical Research and Opinion. 37(12). 2093–2098. 4 indexed citations
3.
Gurulingappa, Harsha, Luca Toldo, Abdul Mateen Rajput, et al.. (2013). Automatic detection of adverse events to predict drug label changes using text and data mining techniques. Pharmacoepidemiology and Drug Safety. 22(11). 1189–1194. 31 indexed citations
4.
Rengelshausen, Jens, Jürgen Burhenne, Yorki Tayrouz, et al.. (2004). Pharmacokinetic interaction of chloroquine and methylene blue combination against malaria. European Journal of Clinical Pharmacology. 60(10). 709–715. 70 indexed citations
5.
Fricker, Ruth, Christiane Hesse, Johanna Weiß, et al.. (2004). Endothelial venodilator response in carriers of genetic polymorphisms involved in NO synthesis and degradation. British Journal of Clinical Pharmacology. 58(2). 169–177. 16 indexed citations
6.
Martin‐Facklam, Meret, Jens Rengelshausen, Yorki Tayrouz, et al.. (2004). Dose individualisation in patients with renal insufficiency: does drug labelling support optimal management?. European Journal of Clinical Pharmacology. 60(11). 807–811. 24 indexed citations
7.
Mikus, Gerd, Jürgen Burhenne, Reinhard Ding, et al.. (2004). Reduction of Saquinavir Exposure by Coadministration of Loperamide. Clinical Pharmacokinetics. 43(14). 1015–1024. 6 indexed citations
8.
Walter‐Sack, I., Reinhard Ding, Matthias Läng, et al.. (2004). Assessment of Levothyroxine Sodium Bioavailability. Clinical Pharmacokinetics. 43(14). 1037–1053. 19 indexed citations
9.
Tayrouz, Yorki, Reinhard Ding, Jürgen Burhenne, et al.. (2003). Pharmacokinetic and pharmaceutic interaction between digoxin and Cremophor RH40. Clinical Pharmacology & Therapeutics. 73(5). 397–405. 76 indexed citations
10.
Tayrouz, Yorki. (2001). Ritonavir increases loperamide plasma concentrations without evidence for P-glycoprotein involvement. Clinical Pharmacology & Therapeutics. 70(5). 405–414. 31 indexed citations
11.
12.
Tayrouz, Yorki, Reinhard Ding, Rolf Aderjan, et al.. (2001). Ritonavir increases loperamide plasma concentrations without evidence for P‐glycoprotein involvement. Clinical Pharmacology & Therapeutics. 70(5). 405–414. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kosuke Doki Breakdown of academic impact, for papers by PE Rolan Breakdown of academic impact, for papers by G. Ahr Breakdown of academic impact, for papers by Dale K. Yu Breakdown of academic impact, for papers by Seong Bok Jang Breakdown of academic impact, for papers by Shiew-Mei Huang Breakdown of academic impact, for papers by Reinhard Ding Breakdown of academic impact, for papers by Kerstin Röhss Breakdown of academic impact, for papers by Ramana Uppoor Breakdown of academic impact, for papers by Festus A. Ogunbona
Rankless by CCL
2026